Dalmau Llorca, M.R.; Hernández Rojas, Z.; Castro Blanco, E.; Carrasco-Querol, N.; Gonçalves, A.Q.; Espuny Cid, A.; Fernández Sáez, J.; GarcÃa-Goñi, M.; Pérez-VillacastÃn, J.; Aguilar MartÃn, C.
Clinical Outcome and Costs Based on the Degree of Vitamin K Antagonist Control for Non-Valvular Atrial Fibrillation. J. Clin. Med. 2025, 14, 998.
https://doi.org/10.3390/jcm14030998
AMA Style
Dalmau Llorca MR, Hernández Rojas Z, Castro Blanco E, Carrasco-Querol N, Gonçalves AQ, Espuny Cid A, Fernández Sáez J, GarcÃa-Goñi M, Pérez-VillacastÃn J, Aguilar MartÃn C.
Clinical Outcome and Costs Based on the Degree of Vitamin K Antagonist Control for Non-Valvular Atrial Fibrillation. Journal of Clinical Medicine. 2025; 14(3):998.
https://doi.org/10.3390/jcm14030998
Chicago/Turabian Style
Dalmau Llorca, M. Rosa, Zojaina Hernández Rojas, Elisabet Castro Blanco, Noèlia Carrasco-Querol, Alessandra Queiroga Gonçalves, Anna Espuny Cid, José Fernández Sáez, Manuel GarcÃa-Goñi, Julián Pérez-VillacastÃn, and Carina Aguilar MartÃn.
2025. "Clinical Outcome and Costs Based on the Degree of Vitamin K Antagonist Control for Non-Valvular Atrial Fibrillation" Journal of Clinical Medicine 14, no. 3: 998.
https://doi.org/10.3390/jcm14030998
APA Style
Dalmau Llorca, M. R., Hernández Rojas, Z., Castro Blanco, E., Carrasco-Querol, N., Gonçalves, A. Q., Espuny Cid, A., Fernández Sáez, J., GarcÃa-Goñi, M., Pérez-VillacastÃn, J., & Aguilar MartÃn, C.
(2025). Clinical Outcome and Costs Based on the Degree of Vitamin K Antagonist Control for Non-Valvular Atrial Fibrillation. Journal of Clinical Medicine, 14(3), 998.
https://doi.org/10.3390/jcm14030998